Updated
AnaptysBioANAB · Healthcare
$46.45+1.91%
Market cap$1.4B
IndustryBiotechnology

AnaptysBio (ANAB) Superinvestor holders

14 of the superinvestors we track hold AnaptysBio (ANAB) in their latest 13F filings, $117M in total.

Summary

The largest holder is David Shaw (D. E. Shaw & Co.), with $36M, 0.0% of the portfolio.

In their latest quarter: 2 opened a new position, 4 added, 8 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
David Shaw
D. E. Shaw & Co.
Trimmed 539,666$36M 0.0%Q2 2026
Arrowstreet Capital Trimmed 488,651$33M 0.0%Q2 2026
Two Sigma
Two Sigma Investments
Trimmed 262,995$18M 0.0%Q2 2026
Ensign Peak
Ensign Peak Advisors
Trimmed 107,096$7M 0.0%Q2 2026
Adam Katz
Irenic Capital Management
New position 70,447$5M 0.3%Q2 2026
Jim Simons
Renaissance Technologies
Trimmed 58,300$4M 0.0%Q2 2026
David Vogel
Voloridge Investment Management
Trimmed 57,555$4M 0.0%Q2 2026
Cliff Asness
AQR Capital Management
Added 46,323$3M 0.0%Q2 2026
Paul Marshall
Marshall Wace
Trimmed 43,822$3M 0.0%Q2 2026
Paul Tudor Jones
Tudor Investment Corp
Added 20,019$1M 0.0%Q2 2026
Alan Howard
Brevan Howard
Added 13,329$899,708 0.0%Q2 2026
Acadian
Acadian Asset Management
Added 12,211$611,000 0.0%Q3 2026
Joel Greenblatt
Gotham Asset Management
Trimmed 6,292$424,710 0.0%Q2 2026
Fred DiSanto
Ancora Holdings
New position 5,000$337,500 0.0%Q2 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 202614
Q1 202615
Q4 202512
Q3 202515
Q2 202511
Q1 202512
Q4 202410
Q3 202415

Questions about AnaptysBio

Which superinvestors own AnaptysBio?

14 of the superinvestors we track hold AnaptysBio (ANAB) in their latest 13F filings, $117M in total. David Shaw, Arrowstreet Capital, Two Sigma, Ensign Peak, Adam Katz, Jim Simons.

Who is the largest superinvestor holder of ANAB?

The largest holder is David Shaw (D. E. Shaw & Co.), with $36M, 0.0% of the portfolio.

From AnaptysBio's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind AnaptysBio and thousands of other companies, in one place. Free to start.